[Cholera vaccine].
Ehara
Masahiko
M
Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University.
D000284:Administration, Oral; D000907:Antibodies, Bacterial; D002771:Cholera / Q000175:diagnosis / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy; D022121:Cholera Vaccines / Q000008:administration & dosage / Q000276:immunology; D010861:Fimbriae, Bacterial / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A; D007413:Intestinal Mucosa / Q000276:immunology; D019081:O Antigens / Q000276:immunology; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D041241:Vibrio cholerae O1 / Q000276:immunology / Q000302:isolation & purification
D000907:Antibodies, Bacterial; D022121:Cholera Vaccines; D007070:Immunoglobulin A; D019081:O Antigens; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated